Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 798 results for "erbitux"

Bristol-Myers Squibb gives full responsibility for Erbitux in Japan to Merck
Pharma Letter

Merck to assume responsibility for promoting Erbitux in Japan

Merck has announced that it will take full responsibility for the promotion of Erbitux from Bristol-Myers in Japan, effective from May 1, 2015. "Expanding our oncology presence in Japan is of strategic importance to achieve our long term ambition to ... Individual.com, 1 week ago
[x]  

4 images for erbitux

Pharma Letter, 2 weeks ago
Pharma Letter, 1 week ago
Pharma Letter, 1 week ago
Pharma Letter, 2 weeks ago

Human medicines European public assessment report (EPAR): Erbitux, cetuximab, Revision: 24, Authorised

This is a summary of the European public assessment report (EPAR) for Erbitux. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and ...
 European Medicines Agency3 weeks ago Information sent to healthcare professionals in January about the safety of medicines  MHRA1 month ago Scottish Medicines Consortium: cetuximab (Erbitux)  FirstWord Pharma1 month ago

Erbitux-Drug Insights,2014

Summary 'Erbitux - Drug Insights, 2014' provides Erbitux marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical assessment of the drug, patent ...
 Individual.com1 month ago

Research and Markets: Antibodies in Oncology Drug Pipeline Update 2015 - 354 companies plus partners developing 707 antibody drugs in 1875 developmental projects

The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the second wave in the ...
 Morningstar.com1 month ago Antibodies in Oncology Drug Pipeline Update 2015  Global Information Inc1 month ago Eli Lilly/BMS/Merck KGaA's Erbitux (Colorectal Cancer) - Forecast and Market Analysis to 2023  Individual.com1 month ago Research and Markets: Eli Lilly/BMS/Merck KGaA's Erbitux (Colorectal Cancer) - Forecast and Market Analysis to 2023  TMC Net1 month ago
[x]  

Merck KGaA to Gain Full Marketing Rights to Erbitux in Japan - Analyst Blog

Merck KGaA ( MKGAF ) announced that it will acquire full responsibility for the promotion of Erbitux from Bristol-Myers Squibb Company ( BMY ) in Japan. We remind investors that Erbitux was launched in Japan in Sep 2008 under partnership with ...
 Zacks.com1 week ago
[x]  

Bristol-Myers Beats on Q4 Earnings, 2015 View Disappoints - Analyst Blog

Sales of another oncology drug, Erbitux, slightly improved during the quarter. Erbitux sales increased 1% to $181 million in the reported quarter. Opdivo, which gained accelerated approval in Dec 2014 for the melanoma indication based on tumor ...
 Nasdaq1 month ago Bristol-Myers (BMY) Beats on Q4 Earnings and Revenues - Tale of the Tape  Zacks.com1 month ago Bristol-Myers Squibb Q4 net income off 98%  Seeking Alpha1 month ago

ELI LILLY : An Application for the Trademark "ACCESS ERBITUX" Has Been Filed by Eli Lilly

By a News Reporter-Staff News Editor at Managed Care Weekly Digest -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a trademark application has been made for "ACCESS ERBITUX" by Robert E. Lee , Jr., ...
 4 Traders1 month ago An Application for the Trademark "ACCESS ERBITUX" Has Been Filed by Eli Lilly  Insurance News Net1 month ago

SMC recommends Erbitux for use in the first line treatment of metastatic bowel cancer patients in Scotland

Erbitux (cetuximab), in combination with FOLFIRI or FOLFOX, has been recommended for use within NHS Scotland by the Scottish Medicines Consortium (SMC) for the first line treatment of metastatic bowel cancer , a disease which affects over 4,000 new ...
 Medical News Today1 month ago

Erbitux Appears Superior to Avastin for Initial Colorectal Cancer Therapy

Results of the phase III Fire trials were recently published in the medical journal The Lancet Oncology. The results of the study suggest that patients with metastatic colorectal cancer treated with Erbitux (cetuximab) combined with standard ...
 CancerConnect.com1 month ago
Jutia Group

Company Update (NYSE:ACT): (OFFICIAL)-UPDATE 1-Actavis superbug antibiotic gets U.S. approval (Feb. 25)

[Reuters UK Focus] The U.S. Food and Drug Administration on Wednesday approved the use of Actavis Plc (NYSE: ACT news) s antibiotic, Avycaz, to battle drug-resistant bacteria known as superbugs. As a standalone medication, it is used to treat ...
 Jutia Group1 day ago Market Update (NYSE:BMY): Bristol-Myers Squibb Foundation Awards GRU Cancer Center Three-Year, $1.74M Grant to Address Lung Cancer Among Neediest Communities in Central Savannah River Area  Jutia Group4 days ago BRISTOL MYERS SQUIBB CO - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.  Pharmacy Choice2 weeks ago Citi Raises Price Target On Actavis Plc (ACT) To $325; Maintains Buy Rating  Bidness Etc2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - erbitux
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less